Raf
As quinases Raf são componentes-chave da via de sinalização MAPK/ERK, desempenhando um papel crítico na transmissão de sinais da membrana celular para o núcleo. A ativação de Raf leva à fosforilação de MEK, que subsequentemente ativa ERK, influenciando a divisão celular, diferenciação e sobrevivência. Mutações em Raf, particularmente em B-Raf, estão associadas a vários tipos de câncer, tornando Raf um alvo crucial na terapia contra o câncer. Na CymitQuimica, oferecemos uma variedade de inibidores e moduladores de Raf para apoiar sua pesquisa em oncologia, transdução de sinais e desenvolvimento terapêutico.
Foram encontrados 81 produtos para "Raf".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
RAS GTPase inhibitor 1
CAS:RAS GTPase inhibitor 1 is a RAS GTPase inhibitor with potential antitumor activity.Fórmula:C27H28ClF4N5O2Pureza:98.43%Cor e Forma:SolidPeso molecular:565.99KRPEP-2D acetate
KRPEP-2D acetate: inhibitor targeting K-Ras(G12D) mutant, a crucial cancer-related protein.Fórmula:C110H186N44O27S2Pureza:99.34%Cor e Forma:SolidPeso molecular:2621.06AZ304
CAS:AZ304 is an ATP-competitive dual BRAF kinase inhibitor, potently inhibits BRAF (WT), BRAF (V600E), and wild type CRAF (IC50s: 79/38/68 nM).Fórmula:C27H25N5O2Pureza:99.82%Cor e Forma:SolidPeso molecular:451.52GW 5074
CAS:GW 5074 (Raf1 Kinase Inhibitor I)(IC50=9 nM) is an effective and specific c-Raf inhibitor.Fórmula:C15H8Br2INO2Pureza:99.32%Cor e Forma:Yellow SolidPeso molecular:520.94Kobe2602
CAS:Kobe 2602 is an inhibitor of Ras that exhibits anticancer chemotherapeutic activities.Fórmula:C14H9F4N5O4SPureza:98.36% - 99.39%Cor e Forma:SolidPeso molecular:419.31Takeda-6d
CAS:Takeda-6d is a novel, potent DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with IC50 of 7.0 nM and 2.2 nM, respectively.Fórmula:C27H19ClFN5O3SPureza:98.27%Cor e Forma:Yellow SolidPeso molecular:547.99Ref: TM-T22436
1mg92,00€2mg128,00€5mg178,00€1mL*10mM (DMSO)243,00€10mg268,00€25mg439,00€50mg610,00€100mg820,00€200mg1.099,00€L-779450
CAS:L-779450, an effective, ATP-competitive Raf kinase inhibitor (IC50: 10 nM) , displays >7, >30 and >70-fold selectivity over p38α, GSK3β and Lck respectively.Fórmula:C20H14ClN3OPureza:98.48%Cor e Forma:SolidPeso molecular:347.8Raf inhibitor 2
CAS:Raf inhibitor 2 (CID 25014542) is novel inhibitor of Raf kinases.Fórmula:C15H8Br2ClNO2Pureza:98.53%Cor e Forma:White SolidPeso molecular:429.49TAK-632
CAS:TAK-632 is a potent pan-Raf inhibitor.Fórmula:C27H18F4N4O3SPureza:98% - 99.5%Cor e Forma:SolidPeso molecular:554.52Encorafenib
CAS:Encorafenib (LGX818) is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity.Fórmula:C22H27ClFN7O4SPureza:99.56% - 99.84%Cor e Forma:SolidPeso molecular:540.01Ro 5126766
CAS:RO5126766 (CH5126766) is a dual RAF/MEK inhibitor with IC50 of 8.2 nM, 19 nM, 56 nM, and 160 nM for BRAF V600E, BRAF, CRAF, and MEK1, respectively. Phase 1.Fórmula:C21H18FN5O5SPureza:98.3% - 98.81%Cor e Forma:White SolidPeso molecular:471.46Ref: TM-T6971
1mg54,00€2mg78,00€5mg109,00€1mL*10mM (DMSO)112,00€10mg169,00€25mg311,00€50mg500,00€100mg718,00€Regorafenib
CAS:Regorafenib (BAY 73-4506) is a multi-targeted receptor tyrosine kinase inhibitor that inhibits RET, C-RAF, VEGFR2, c-Kit, VEGFR1, and PDGFRβ and is orallyFórmula:C21H15ClF4N4O3Pureza:98% - 99.95%Cor e Forma:SolidPeso molecular:482.82Ref: TM-T1792
5mg34,00€10mg49,00€1mL*10mM (DMSO)54,00€25mg75,00€50mg90,00€100mg137,00€200mg175,00€500mg294,00€Regorafenib monohydrate
CAS:Regorafenib Monohydrate is a novel oral multikinase inhibitor with IC50 values of 13, 4.2, 46, 22, 7, 1.5, 2.5, 28, 19 nM for VEGFR1, murine VEGFR2, murineFórmula:C21H17ClF4N4O4Pureza:99.69%Cor e Forma:SolidPeso molecular:500.83Ref: TM-T1792L
5mg34,00€10mg46,00€1mL*10mM (DMSO)55,00€25mg65,00€50mg94,00€100mg133,00€200mg197,00€500mg329,00€SB-590885
CAS:SB590885 is an effective B-Raf inhibitor (Ki: 0.16 nM, in a cell-free assay).Fórmula:C27H27N5O2Pureza:95.42% - 99.06%Cor e Forma:SolidPeso molecular:453.54AD80
CAS:AD80, a multikinase inhibitor, inhibits RET, RAF, SRCand S6K, with greatly reduced mTOR activity.Fórmula:C22H19F4N7OPureza:99.49% - 99.75%Cor e Forma:SolidPeso molecular:473.43Ref: TM-T4301
1mg44,00€1mL*10mM (DMSO)90,00€5mg96,00€10mg138,00€25mg268,00€50mg439,00€100mg645,00€500mg1.333,00€K-Ras(G12C) inhibitor 9
CAS:K-Ras(G12C) inhibitor 9 is an allosteric inhibitor of oncogenic K-Ras(G12C).Fórmula:C16H21ClIN3O4SPureza:97.33% - 97.45%Cor e Forma:SolidPeso molecular:513.78Ref: TM-T6556
1mg34,00€5mg78,00€10mg108,00€1mL*10mM (DMSO)108,00€25mg215,00€50mg311,00€100mg425,00€200mg597,00€BI-882370
CAS:BI-882370 is a specific RAF kinase inhibitor.Fórmula:C28H33F2N7O2SPureza:97.33% - 99.07%Cor e Forma:SolidPeso molecular:569.67Plx-4032
CAS:Plx-4032 (Vemurafenib) is a small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma.Fórmula:C23H18ClF2N3O3SPureza:98.53% - 99.94%Cor e Forma:SolidPeso molecular:489.92RAF265
CAS:RAF265 (CHIR-265) inhibits C-Raf/B-Raf/V600E (IC50: 3-60 nM), blocks VEGFR2 (EC50: 30 nM), in Phase 2 trials.Fórmula:C24H16F6N6OPureza:99.56%Cor e Forma:White SolidPeso molecular:518.41Ref: TM-T6296
1mg44,00€2mg59,00€5mg93,00€1mL*10mM (DMSO)94,00€10mg140,00€25mg253,00€50mg413,00€100mg605,00€PLX8394
CAS:Plixorafenib (PLX8394) is an orally active inhibitor of the serine/threonine protein kinase B-Raf (BRAF) protein.Cost-effective and quality-assured.Fórmula:C25H21F3N6O3SPureza:98.75% - >99.99%Cor e Forma:SolidPeso molecular:542.53
